Clinical Trial Update: A Phase Ia Clinical Trial of HW241045 [Phase 1]

View source ↗

Summary

A Phase 1 trial of HW241045 in healthy volunteers and idiopathic pulmonary fibrosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• HW241045

Snippet

Sponsor: Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. | Conditions: Healthy Volunteers, IPF | Phase 1 | Status: RECRUITING